Real-life data of major and minor bleeding events with direct oral anticoagulants in the one-year follow-up period: The NOAC-TURK study

Ítems similars

• Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR
  per: Sadik Volkan Emren, et al.
  Publicat: (2020-01-01)
• The role of -omics technology in the pathophysiology, diagnosis, and treatment of cardiovascular diseases
  per: Ümit Yaşar Sinan, et al.
  Publicat: (2017-07-01)
• Some Thoughts About Warfarin and NOACS
  per: C. Richard Conti
  Publicat: (2017-01-01)
• Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
  per: Blann A
  Publicat: (2015-08-01)
• Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
  per: Jovanović Dejana R.
  Publicat: (2020-01-01)